Literature DB >> 9535830

In vitro cleavage of internally quenched fluorogenic human proparathyroid hormone and proparathyroid-related peptide substrates by furin. Generation of a potent inhibitor.

C Lazure1, D Gauthier, F Jean, A Boudreault, N G Seidah, H P Bennett, G N Hendy.   

Abstract

The cleavage of parathyroid hormone (PTH) from its precursor proparathyroid hormone (pro-PTH) is accomplished efficiently by the proprotein convertase furin (Hendy, G. N., Bennett, H. P. J., Gibbs, B. F., Lazure, C., Day, R., and Seidah, N. G. (1995) J. Biol. Chem. 270, 9517-9525). We also showed that a synthetic peptide comprising the -6 to +7 sequence of human pro-PTH is appropriately cleaved by purified furin in vitro. The human pro-PTH processing site Lys-Ser-Val-Lys-Lys-Arg differs from the consensus furin site Arg-Xaa-(Lys/Arg)-Arg that is represented by Arg-Arg-Leu-Lys-Arg in the cleavage site of pro-PTH-related peptide (pro-PTHrP). An earlier study demonstrated that an internally quenched fluorogenic substrate bearing an O-aminobenzoyl fluorescent donor at the NH2 terminus and an acceptor 3-nitrotyrosine near the COOH terminus was appropriately cleaved by the convertases furin and PC1 (Jean, F., Basak, A., DiMaio, J., Seidah, N. G., and Lazure, C. (1995) Biochem. J. 307, 689-695). Here, we have synthesized a series of internally quenched fluorogenic substrates based upon the pro-PTH and pro-PTHrP sequences to determine which residues are important for furin cleavage. Purified recombinant furin and PC1 cleaved the human pro-PTH internally quenched substrate at the appropriate site in an identical manner to that observed with the nonfluorescent peptide. Several substitutions in the P6-P3 sequence were well tolerated; however, replacement of the Lys at the P6 position with Gly and replacement of the P3 Lys by an acidic residue led to markedly compromised cleavage by furin. Furin activity was very sensitive to substitution in P' positions. Replacement of Ser at P1' with Gly and Val at P2' with Ala generated substrates that were less well cleaved. Substitution at the P1' position of Val for Ser in conjunction with Ala for Val at P2', as well as a single substitution of Lys for Val at P2', generated specific inhibitors of furin cleavage. The findings of this study open the way to the rational design of inhibitors of furin with therapeutic potential.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9535830     DOI: 10.1074/jbc.273.15.8572

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  17 in total

1.  Characterization of PHEX endopeptidase catalytic activity: identification of parathyroid-hormone-related peptide107-139 as a substrate and osteocalcin, PPi and phosphate as inhibitors.

Authors:  G Boileau; H S Tenenhouse; L Desgroseillers; P Crine
Journal:  Biochem J       Date:  2001-05-01       Impact factor: 3.857

2.  Yeast Ste23p shares functional similarities with mammalian insulin-degrading enzymes.

Authors:  Benjamin J Alper; Jarrad W Rowse; Walter K Schmidt
Journal:  Yeast       Date:  2009-11       Impact factor: 3.239

3.  Ste24p Mediates Proteolysis of Both Isoprenylated and Non-prenylated Oligopeptides.

Authors:  Emily R Hildebrandt; Buenafe T Arachea; Michael C Wiener; Walter K Schmidt
Journal:  J Biol Chem       Date:  2016-04-29       Impact factor: 5.157

4.  Stability of mutant serpin/furin complexes: dependence on pH and regulation at the deacylation step.

Authors:  Erick K Dufour; Antoine Désilets; Jean-Michel Longpré; Richard Leduc
Journal:  Protein Sci       Date:  2005-02       Impact factor: 6.725

5.  Comparative tissue distribution of the processing enzymes "prohormone thiol protease," and prohormone convertases 1 and 2, in human PTHrP-producing cell lines and mammalian neuroendocrine tissues.

Authors:  L J Deftos; D Burton; R H Hastings; R Terkeltaub; V Y Hook
Journal:  Endocrine       Date:  2001-07       Impact factor: 3.633

6.  Etiological point mutations in the hereditary multiple exostoses gene EXT1: a functional analysis of heparan sulfate polymerase activity.

Authors:  P K Cheung; C McCormick; B E Crawford; J D Esko; F Tufaro; G Duncan
Journal:  Am J Hum Genet       Date:  2001-06-05       Impact factor: 11.025

7.  Comparative study of the binding pockets of mammalian proprotein convertases and its implications for the design of specific small molecule inhibitors.

Authors:  Sun Tian; Wu Jianhua
Journal:  Int J Biol Sci       Date:  2010-02-03       Impact factor: 6.580

8.  Processing of alpha4 integrin by the proprotein convertases: histidine at position P6 regulates cleavage.

Authors:  Eric Bergeron; Ajoy Basak; Etienne Decroly; Nabil G Seidah
Journal:  Biochem J       Date:  2003-07-15       Impact factor: 3.857

Review 9.  Proprotein convertases in tumor progression and malignancy: novel targets in cancer therapy.

Authors:  Abdel-Majid Khatib; Géraldine Siegfried; Michel Chrétien; Peter Metrakos; Nabil G Seidah
Journal:  Am J Pathol       Date:  2002-06       Impact factor: 4.307

10.  A study of human furin specificity using synthetic peptides derived from natural substrates, and effects of potassium ions.

Authors:  Mario A Izidoro; Iuri E Gouvea; Jorge A N Santos; Diego M Assis; Vitor Oliveira; Wagner A S Judice; Maria A Juliano; Iris Lindberg; Luiz Juliano
Journal:  Arch Biochem Biophys       Date:  2009-05-27       Impact factor: 4.013

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.